• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1 型糖尿病肥胖患儿趋化因子谱与心脏代谢状态的关联模式不同。

Distinct association patterns of chemokine profile and cardiometabolic status in children and adolescents with type 1 diabetes and obesity.

机构信息

Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University Hospital Center Zagreb, Zagreb, Croatia.

Pediatric Clinic, Children's Hospital Zagreb, Zagreb, Croatia.

出版信息

Front Endocrinol (Lausanne). 2024 Jul 23;15:1335371. doi: 10.3389/fendo.2024.1335371. eCollection 2024.

DOI:10.3389/fendo.2024.1335371
PMID:39109081
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11300205/
Abstract

OBJECTIVE

We compared peripheral blood (PBL) chemokine ligand/receptor profiles in children and adolescents with type 1 diabetes mellitus (T1D) or obesity (OB) (both involving inflammation and vascular complications) to identify their associations with cardiometabolic risk factors.

MATERIALS AND METHODS

PBL samples from children and adolescents (12-18 years) included: healthy controls (n=29), patients with T1D (n=31) and OB subjects (n=34). Frequency of mononuclear cell populations and chemokine receptor expression (CCR2, CCR4, CXCR3, CXCR4) were determined by flow cytometry. Chemokine levels of CCL2, CCL5, CXCL10 and CXCL11 were measured by bead-based assay and CXCL12 by ELISA. Data were correlated with cardiovascular, metabolic and inflammatory parameters.

RESULTS

The proportion of CD14 monocytes was higher in T1D, whereas the proportion of CD19 B lymphocytes was higher and CD3 T lymphocytes was lower in OB. The level of CCL2 was higher in T1D (241.0 (IQR 189.6-295.3) pg/mL in T1D vs 191.5 (IQR 158.0-254.7) pg/mL in control, p=0.033), CXCL11 was lower in OB (6.6 (IQR 4.9-7.7) pg/mL in OB vs 8.2 (IQR 6.9-11.3) pg/mL in control, p=0.018) and CXCL12 was lower in both diseases (2.0 (IQR 1.8-2.5) ng/mL in T1D, 2.1 (IQR 1.9-2.4) ng/mL in OB vs 2.4 (IQR 2.2-2.5) ng/mL in control, p=0.016). Numerous significant associations were found for chemokine ligand/receptor profiles and clinical data. Among these, we are suggesting the most important indicators of cardiometabolic risk in T1D: positive associations of CCR2 monocytes with blood pressure and CCL12 levels with urine albumin-to-creatinine ratio (ACR), inverse association of CXCR3 B lymphocytes with AST but positive with triglycerides; and OB: positive associations of CXCL12 levels with triglycerides and AST/ALT, inverse association of CCR4 and CXCR3 monocytes with ACR. Both diseases share positive associations for CCR4 T lymphocytes and blood pressure, inverse associations of CXCR4 subsets with ACR and CXCR3 T lymphocytes with lipid profile.

CONCLUSION

Significantly changed chemokine ligand/receptor profiles were found in both T1D and OB even at a young age. Although different associations with cardiometabolic risk factors indicate disease-specific changes, overlapping pattern was found for the associations between CCR4 T lymphocytes and vascular inflammation, CXCR4 subsets and albuminuria as well as CXCR3 T lymphocytes and dyslipidemia. Thus, chemokine axes might present potential therapeutic targets for disease-related morbidity.

摘要

目的

我们比较了患有 1 型糖尿病(T1D)或肥胖症(OB)(均涉及炎症和血管并发症)的儿童和青少年外周血(PBL)趋化因子配体/受体谱,以确定它们与心血管代谢危险因素的关联。

材料和方法

儿童和青少年(12-18 岁)的 PBL 样本包括:健康对照组(n=29)、T1D 患者(n=31)和 OB 受试者(n=34)。通过流式细胞术测定单核细胞群体和趋化因子受体表达(CCR2、CCR4、CXCR3、CXCR4)的频率。通过基于珠子的测定法测量趋化因子 CCL2、CCL5、CXCL10 和 CXCL11 的水平,并通过 ELISA 测量 CXCL12 的水平。将数据与心血管、代谢和炎症参数相关联。

结果

T1D 患者中 CD14 单核细胞的比例较高,而 OB 患者中 CD19 B 淋巴细胞的比例较高,CD3 T 淋巴细胞的比例较低。T1D 患者中 CCL2 的水平较高(T1D 中 241.0(IQR 189.6-295.3)pg/mL,对照组中 191.5(IQR 158.0-254.7)pg/mL,p=0.033),OB 患者中 CXCL11 的水平较低(OB 中 6.6(IQR 4.9-7.7)pg/mL,对照组中 8.2(IQR 6.9-11.3)pg/mL,p=0.018),两种疾病中 CXCL12 的水平均较低(T1D 中 2.0(IQR 1.8-2.5)ng/mL,OB 中 2.1(IQR 1.9-2.4)ng/mL,对照组中 2.4(IQR 2.2-2.5)ng/mL,p=0.016)。趋化因子配体/受体谱与临床数据之间存在许多显著关联。在这些关联中,我们提出了 T1D 中心血管代谢风险的最重要指标:CCR2 单核细胞与血压的正相关,CCL12 水平与尿白蛋白/肌酐比值(ACR)的正相关,CXCR3 B 淋巴细胞与 AST 的负相关,但与甘油三酯的正相关;OB:CXCL12 水平与甘油三酯和 AST/ALT 的正相关,CCR4 和 CXCR3 单核细胞与 ACR 的负相关。两种疾病均显示 CCR4 T 淋巴细胞和血压的正相关,CCR4 亚群与 ACR 和 CXCR3 T 淋巴细胞与脂质谱的负相关。

结论

即使在儿童和青少年时期,T1D 和 OB 也存在明显改变的趋化因子配体/受体谱。尽管与心血管代谢危险因素的关联不同表明存在疾病特异性变化,但在 CCR4 T 淋巴细胞与血管炎症、CCR4 亚群与白蛋白尿以及 CXCR3 T 淋巴细胞与血脂异常之间发现了重叠模式。因此,趋化因子轴可能是治疗与疾病相关发病率的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/4624dc1e3b73/fendo-15-1335371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/53f5e796c30b/fendo-15-1335371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/9bcc3ef0cbc1/fendo-15-1335371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/d6f74563248c/fendo-15-1335371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/0dca7536214d/fendo-15-1335371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/14183bcceb8f/fendo-15-1335371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/4624dc1e3b73/fendo-15-1335371-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/53f5e796c30b/fendo-15-1335371-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/9bcc3ef0cbc1/fendo-15-1335371-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/d6f74563248c/fendo-15-1335371-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/0dca7536214d/fendo-15-1335371-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/14183bcceb8f/fendo-15-1335371-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/552b/11300205/4624dc1e3b73/fendo-15-1335371-g006.jpg

相似文献

1
Distinct association patterns of chemokine profile and cardiometabolic status in children and adolescents with type 1 diabetes and obesity.1 型糖尿病肥胖患儿趋化因子谱与心脏代谢状态的关联模式不同。
Front Endocrinol (Lausanne). 2024 Jul 23;15:1335371. doi: 10.3389/fendo.2024.1335371. eCollection 2024.
2
Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.趋化因子信号对于循环破骨细胞祖细胞的归巢和分化增强至关重要。
Arthritis Res Ther. 2017 Jun 15;19(1):142. doi: 10.1186/s13075-017-1337-6.
3
Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA).趋化因子及趋化因子受体分析显示,附着点炎相关关节炎(ERA)患者滑液中干扰素诱导蛋白-10(IP)-10/CXCL10水平升高,CCR5+和CXCR3+ CD4 T细胞数量增加。
Clin Exp Immunol. 2007 Jun;148(3):515-9. doi: 10.1111/j.1365-2249.2007.03377.x. Epub 2007 Mar 21.
4
CXCR3 and CCR5 chemokines in induced sputum from patients with COPD.慢性阻塞性肺疾病患者诱导痰中的CXCR3和CCR5趋化因子
Chest. 2008 Jan;133(1):26-33. doi: 10.1378/chest.07-0393. Epub 2007 Oct 9.
5
Regulation of inflammatory chemokine receptors on blood T cells associated to the circulating versus liver chemokines in dengue fever.登革热患者外周血 T 细胞与循环及肝脏趋化因子相关的炎症性趋化因子受体的调节。
PLoS One. 2012;7(7):e38527. doi: 10.1371/journal.pone.0038527. Epub 2012 Jul 16.
6
Association of glomerular hyperfiltration with serum chemokine levels and metabolic features in prepubertal children with overweight/obesity.肾小球高滤过与青春期前超重/肥胖儿童血清趋化因子水平和代谢特征的关系。
Nutr Metab Cardiovasc Dis. 2020 Jun 25;30(7):1188-1195. doi: 10.1016/j.numecd.2020.03.012. Epub 2020 Mar 24.
7
Expression of CC chemokines CCL2, CCL5, and CCL11 is associated with duration of disease and complications in type-1 diabetes: a study on Iranian diabetic patients.CC趋化因子CCL2、CCL5和CCL11的表达与1型糖尿病的病程及并发症相关:一项针对伊朗糖尿病患者的研究
Clin Lab. 2013;59(9-10):993-1001. doi: 10.7754/clin.lab.2012.120810.
8
Impaired CD4 and CD8 T cell phenotype and reduced chemokine secretion in recent-onset type 1 diabetic children.新发病1型糖尿病儿童的CD4和CD8 T细胞表型受损及趋化因子分泌减少
Clin Exp Immunol. 2008 Sep;153(3):360-8. doi: 10.1111/j.1365-2249.2008.03720.x.
9
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis.趋化因子受体CXCR3和CCR4在人类肺纤维化中的作用。
Am J Respir Crit Care Med. 2006 Feb 1;173(3):310-7. doi: 10.1164/rccm.200502-244OC. Epub 2005 Oct 20.
10
Altered chemokine receptor profile on circulating leukocytes in human heart failure.人类心力衰竭时循环白细胞上趋化因子受体谱的改变。
Cell Biochem Biophys. 2006;44(1):83-101. doi: 10.1385/CBB:44:1:083.

本文引用的文献

1
Serum stromal cell-derived factor-1 concentrations are increased and associated with nonalcoholic fatty liver disease in children with obesity.血清基质细胞衍生因子-1 浓度升高与肥胖儿童非酒精性脂肪性肝病有关。
BMC Endocr Disord. 2024 May 10;24(1):67. doi: 10.1186/s12902-024-01597-2.
2
Monocyte Chemoattractant Protein-1 (MCP-1), Activin-A and Clusterin in Children and Adolescents with Obesity or Type-1 Diabetes Mellitus.肥胖或1型糖尿病儿童及青少年体内的单核细胞趋化蛋白-1(MCP-1)、激活素A和簇集蛋白
Diagnostics (Basel). 2024 Feb 19;14(4):450. doi: 10.3390/diagnostics14040450.
3
CXCL12-CXCR4 mediates CD57 CD8 T cell responses in the progression of type 1 diabetes.
CXCL12-CXCR4 介导 1 型糖尿病进展中的 CD57 CD8 T 细胞应答。
J Autoimmun. 2024 Feb;143:103171. doi: 10.1016/j.jaut.2024.103171. Epub 2024 Feb 1.
4
Acute and Chronic Adverse Outcomes of Type 1 Diabetes.1 型糖尿病的急性和慢性不良结局。
Endocrinol Metab Clin North Am. 2024 Mar;53(1):123-133. doi: 10.1016/j.ecl.2023.09.004. Epub 2023 Oct 17.
5
CXCR4/CXCL12 axis: "old" pathway as "novel" target for anti-inflammatory drug discovery.CXCR4/CXCL12 轴:“旧”通路作为抗炎药物发现的“新”靶点。
Med Res Rev. 2024 May;44(3):1189-1220. doi: 10.1002/med.22011. Epub 2024 Jan 4.
6
Structural insights into the activation and inhibition of CXC chemokine receptor 3.CXCR3 趋化因子受体的激活和抑制的结构见解。
Nat Struct Mol Biol. 2024 Apr;31(4):610-620. doi: 10.1038/s41594-023-01175-5. Epub 2024 Jan 4.
7
Structure basis for the modulation of CXC chemokine receptor 3 by antagonist AMG487.拮抗剂AMG487对CXC趋化因子受体3的调节作用的结构基础
Cell Discov. 2023 Nov 28;9(1):119. doi: 10.1038/s41421-023-00617-0.
8
Autoreactive B cells in rheumatoid arthritis include mainly activated CXCR3+ memory B cells and plasmablasts.类风湿关节炎中的自身反应性 B 细胞主要包括活化的 CXCR3+记忆 B 细胞和浆母细胞。
JCI Insight. 2023 Oct 23;8(20):e172006. doi: 10.1172/jci.insight.172006.
9
RAGE signaling regulates the progression of diabetic complications.晚期糖基化终末产物受体信号传导调节糖尿病并发症的进展。
Front Pharmacol. 2023 Mar 16;14:1128872. doi: 10.3389/fphar.2023.1128872. eCollection 2023.
10
CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy.CC 趋化因子受体 4(CCR4)作为一种可能的新治疗靶点。
Int J Mol Sci. 2022 Dec 9;23(24):15638. doi: 10.3390/ijms232415638.